NCT00371761
PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278) treatment 3 completed NCT03097952
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu No drug interventions Not Available Not Available recruiting NCT02995252
The HOPE Study: Characterizing Patients With Hepatitis B and C Not Available Not Available recruiting NCT02612506
Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers No drug interventions treatment 1 completed NCT02967939
Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients treatment 3 completed NCT03018821
The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B treatment Not Available unknown_status NCT03023787
Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers No drug interventions treatment 1 completed NCT04886102
Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French Guiana No drug interventions Not Available Not Available unknown_status NCT06128421
Individual Nutrition Support in HBV-ACLF Patients at Nutrition Risk No drug interventions treatment Not Available recruiting NCT02327702
Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients treatment 4 unknown_status NCT02128503
Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease No drug interventions prevention Not Available terminated NCT01519921
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. treatment 4 completed NCT00686790
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) treatment 3 completed NCT00230503
Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B treatment 2 completed NCT00230490
Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201 treatment 2 terminated NCT00111943
Safety and Acceptability of a Vaginal Microbicide prevention 2 completed NCT06550128
Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Subjects With Chronic Hepatitis B (CHB). No drug interventions treatment 2 recruiting NCT06525909
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B No drug interventions Not Available Not Available recruiting NCT06041022
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B No drug interventions Not Available Not Available not_yet_recruiting NCT05977283
HBsAg Declined Patients Follow-up Study No drug interventions Not Available Not Available recruiting NCT05937178
Real-world Study Optimizing Nucleotide-analogues No drug interventions Not Available Not Available recruiting NCT05630807
Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) No drug interventions treatment 3 active_not_recruiting NCT05473806
Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes treatment 4 unknown_status NCT05382013
Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment prevention 4 recruiting NCT05376124
Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory No drug interventions Not Available Not Available recruiting NCT05276297
A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy treatment 2 active_not_recruiting NCT05107778
Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBV treatment 2 completed NCT04805034
Predictive Model for Prognosis of Chronic HBV Infection Mothers No drug interventions Not Available Not Available unknown_status NCT04782375
Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B No drug interventions supportive_care 4 active_not_recruiting NCT04724785
Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients No drug interventions Not Available Not Available unknown_status NCT04538651
A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in China No drug interventions Not Available Not Available unknown_status NCT04465916
Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD) treatment 2 terminated NCT04365933
A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir treatment 2 completed NCT04211805
Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B Not Available Not Available unknown_status NCT04160897
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis Not Available Not Available unknown_status NCT04133259
Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients treatment 2 unknown_status NCT03772249
Study of Safety and Tolerability of DCR HBVS No drug interventions treatment 1 completed NCT03485534
Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients treatment 4 completed NCT03681132
The Norwegian Nucleoside Analogue Stop Study No drug interventions treatment 4 completed NCT03125213
A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects treatment 2 withdrawn NCT04856085
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection treatment 2 recruiting NCT05242445
A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection basic_science 1 completed NCT05123599
A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection treatment 1 completed NCT05550519
A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment No drug interventions other 0 withdrawn NCT03468907
The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation prevention 4 completed NCT03272009
Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects treatment 1 completed NCT03320616
EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection No drug interventions treatment 1 completed NCT02766933
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study No drug interventions Not Available Not Available active_not_recruiting NCT02693652
A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine No drug interventions treatment 1 / 2 completed NCT02631096
Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy No drug interventions treatment 2 completed NCT02392598
A Hepatitis B With Hepatic Steatosis Study No drug interventions Not Available Not Available unknown_status NCT02498275
Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients No drug interventions Not Available Not Available terminated NCT02327416
A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study) treatment 3 unknown_status NCT02366247
Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B treatment 3 unknown_status NCT02201407
An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study Not Available Not Available completed NCT02167113
Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay No drug interventions Not Available Not Available completed NCT02065336
A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection treatment 2 terminated NCT01886300
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam No drug interventions Not Available Not Available terminated NCT01855997
A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue Not Available Not Available completed NCT01734018
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT01667432
An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B Not Available Not Available completed NCT01475851
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs No drug interventions treatment 3 completed NCT01376154
Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) Not Available Not Available completed NCT01237496
Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253 treatment 3 completed NCT01107483
Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection No drug interventions Not Available Not Available completed NCT01086085
A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive treatment 4 completed NCT01023217
Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir treatment 4 completed NCT00962975
A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies treatment 1 completed NCT00838071
Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation prevention 3 completed NCT00800787
Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation treatment 3 withdrawn NCT00718887
Suboptimal Responders to Adefovir Switching to Entecavir treatment 4 completed NCT00651209
A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) treatment 4 completed NCT00625339
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA treatment 4 completed NCT00637663
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA treatment 4 completed NCT00537537
To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) treatment 4 completed NCT00403585
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 treatment 4 completed NCT00120354
Long-Term Lamivudine Therapy for Chronic Hepatitis B No drug interventions treatment 4 completed NCT00076336
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis treatment 3 completed NCT04059198
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus treatment 2 terminated NCT05182463
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients treatment 4 recruiting NCT06452693
A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B No drug interventions treatment 1 / 2 not_yet_recruiting NCT06216470
Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION] treatment 2 recruiting NCT06196632
Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy No drug interventions Not Available Not Available recruiting NCT06115993
A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients No drug interventions treatment 1 / 2 recruiting NCT06023745
Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B. No drug interventions Not Available Not Available recruiting NCT06000657
The Efficacy and Safety of Switching to Vemliver Tab From Entecavir in Chronic Hepatitis B Patients Who Pretreated With Entecavir No drug interventions treatment 4 active_not_recruiting NCT05922306
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B treatment 0 recruiting NCT05708560
Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study No drug interventions Not Available Not Available recruiting NCT05630820
Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) No drug interventions treatment 3 active_not_recruiting NCT05398393
An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment treatment Not Available unknown_status NCT05391360
Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study other 1 completed NCT05172453
Mother-to-child Transmission of HBV in China No drug interventions Not Available Not Available recruiting NCT05168293
Effect of Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood Mononuclear Cells No drug interventions Not Available Not Available unknown_status NCT05057065
A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB No drug interventions Not Available Not Available unknown_status NCT05045261
ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation No drug interventions treatment 2 unknown_status NCT05005507
A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection treatment 2 terminated NCT04597164
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF No drug interventions Not Available Not Available unknown_status NCT04585165
User-friendly HIV Testing and Counseling Services No drug interventions Not Available Not Available recruiting NCT04536532
Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study treatment 1 / 2 terminated NCT04289987
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine No drug interventions treatment 2 completed NCT04237376
Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical Transmission Not Available Not Available unknown_status NCT04248426
A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection treatment 1 completed NCT04225715
A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B treatment 2 completed NCT04201808
Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides treatment 4 unknown_status NCT04166266
Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection No drug interventions Not Available Not Available recruiting NCT04129554
A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection treatment 2 completed NCT04070079
Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B: treatment 4 unknown_status NCT03932513
Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients treatment 2 terminated NCT03866187
Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection No drug interventions treatment 1 / 2 active_not_recruiting NCT03778567
Renoprotective Effects of Telbivudine in Chronic Hepatitis B treatment 4 completed NCT03759782
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity treatment 3 unknown_status NCT04684914
HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB) No drug interventions treatment 2 terminated NCT04035837
The Clinical Cure Project of Chronic Hepatitis B in China treatment 4 recruiting NCT05423106
A Single and Multiple Ascending Dose Study of JNJ-64457744 treatment 1 terminated NCT05870969
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) No drug interventions Not Available Not Available recruiting NCT05867056
Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection No drug interventions treatment 1 recruiting NCT03469583
Drug Drug Interaction Study for EYP001 With Entecavir treatment 1 completed NCT03463369
A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed No drug interventions other 1 completed NCT03358108
A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study) No drug interventions Not Available Not Available unknown_status NCT03300414
Biologic Basis of Liver Cancer From Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT03258710
A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B treatment 4 completed NCT02826070
EFFORT Further Extension Study treatment 4 unknown_status NCT02956850
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531 No drug interventions treatment 1 completed NCT02974829
REALM China Extension Study No drug interventions Not Available Not Available unknown_status NCT02588937
Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients treatment 4 unknown_status NCT02570191
A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV) treatment 4 completed NCT02482272
Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B treatment 4 unknown_status NCT02605252
New Strategy Study of Functional Cure of Chronic Hepatitis B treatment Not Available unknown_status NCT02604355
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients No drug interventions basic_science 1 terminated NCT02391805
A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection treatment 2 completed NCT02327715
Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients prevention 4 unknown_status NCT02327676
Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients treatment 4 unknown_status NCT02267473
Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function No drug interventions Not Available Not Available unknown_status NCT02224456
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis treatment 4 completed NCT02129829
PROLIFICA - West African Treatment Cohort for Hepatitis B Not Available Not Available completed NCT02097004
Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection treatment 4 completed NCT02081469
Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy No drug interventions health_services_research 4 completed NCT01908660
Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions No drug interventions Not Available Not Available completed NCT01787279
An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B treatment 4 completed NCT01730508
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B Not Available Not Available completed NCT01706575
A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression treatment 2 completed NCT01705704
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT01641536
Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients No drug interventions treatment 1 completed NCT01697501
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253 No drug interventions other 3 completed NCT01521975
A Two-year Study of Telbivudine in HBeAg Negative Hepatitis treatment 4 completed NCT01456312
HBsAg Related Response Guided Therapy treatment 4 unknown_status NCT01480284
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue No drug interventions treatment 3 completed NCT01353742
Lamivudine and Adefovir Dipivoxil Fixed Dose Combination treatment 1 completed NCT01341106
Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection Not Available 4 terminated NCT01310062
The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer No drug interventions Not Available Not Available unknown_status NCT01311947
Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B Not Available Not Available completed NCT01205165
An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) treatment 4 completed NCT01090531
Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy No drug interventions Not Available Not Available unknown_status NCT00940485
A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B treatment 4 completed NCT00986778
Entecavir Plus Adefovir in Lamivudine-Resistant Patients treatment 4 withdrawn NCT00921180
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B treatment 4 unknown_status NCT00962533
EFFicacy Optimization Research of Telbivudine Therapy treatment 4 completed NCT00962871
A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both treatment 1 completed NCT00922207
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B treatment 4 completed NCT00927082
A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B Not Available 4 completed NCT00917761
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B treatment 4 unknown_status NCT00895713
Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation prevention 2 completed NCT00815464
A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B No drug interventions treatment Not Available unknown_status NCT00823550
Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients treatment 4 unknown_status NCT00646503
Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B treatment 4 completed NCT00640588
Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine other 3 completed NCT00614471
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B. treatment 4 completed NCT00487747
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. treatment 4 completed NCT00460850
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B. treatment 4 terminated NCT00410202
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus treatment 3 completed NCT00363155
KRN7000 in Chronic Hepatitis B treatment 1 / 2 completed NCT00347009
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis treatment 4 completed NCT00034359
Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus Infection treatment 2 completed NCT04023721
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor treatment 2 terminated NCT02289300
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients No drug interventions treatment 2 withdrawn NCT06550622
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion No drug interventions Not Available Not Available recruiting NCT06245291
Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection treatment 2 withdrawn NCT05484466
A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB treatment 2 recruiting NCT05470829
A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R No drug interventions treatment 1 completed NCT05286216
The Effect of Education on Drug Compliance and Quality of Life in Hepatitis B Patients No drug interventions prevention Not Available unknown_status NCT05275023
An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants treatment 2 completed NCT05265026
Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic Steatosis No drug interventions treatment Not Available completed NCT05177926
Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF) prevention 4 unknown_status NCT04847440
A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection treatment 2 terminated NCT04780204
Effectiveness of Antiviral Treatment in Cirrhotic Patients With Low-level Hepatitis B Virus DNA Levels treatment 4 recruiting NCT04749368
Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection treatment 2 completed NCT04667104
A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection treatment 2 completed NCT04507269
Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China treatment 2 completed NCT04082338
Chronic HBV Management for Asian American No drug interventions prevention Not Available completed NCT03982186
A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection treatment 2 completed NCT03977857
Prediction Model Based on Computed Tomography Liver Volume for the Short-term Mortality in Hepatitis B Related Acute-on-Chronic No drug interventions Not Available Not Available completed NCT03539016
Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants No drug interventions Not Available Not Available unknown_status NCT05328427
Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B No drug interventions other Not Available not_yet_recruiting NCT05612581
A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection treatment 1 / 2 active_not_recruiting NCT04439539
A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection treatment 2 completed NCT04426968
A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B treatment 2 completed NCT03164889
Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients treatment Not Available terminated NCT03471624
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF) treatment 4 completed NCT03459768
Cohort Study on People Who Inject Drugs in Senegal No drug interventions Not Available Not Available unknown_status NCT03350074
HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy No drug interventions Not Available Not Available completed NCT02726789
Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B treatment 2 completed NCT02791269
A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program treatment 4 completed NCT02826018
A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection No drug interventions treatment 1 terminated NCT02876419
A Long Term Follow-up Study of Patients From the REP 301 Protocol No drug interventions Not Available Not Available completed NCT02952924
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants treatment 1 completed NCT02719808
Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection No drug interventions Not Available Not Available unknown_status NCT02646189
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients treatment 1 / 2 completed NCT02646163
Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients No drug interventions treatment 1 / 2 completed NCT02600117
Use of TDF in Patients With Inactive Chronic Hepatitis B Infection treatment 3 completed NCT02598063
A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B treatment 4 completed NCT02604823
A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV) treatment 4 completed NCT02510963
Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy treatment Not Available unknown_status NCT02499562
A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis treatment 2 completed NCT02338674
TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction treatment 1 / 2 completed NCT02327663
Emtricitabine for Naive Chinese Chronic Hepatitis B Patients treatment 4 unknown_status NCT02327689
Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients treatment 4 unknown_status NCT02360592
Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients treatment 4 completed NCT02366208
Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B treatment 2 completed NCT02195518
Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study treatment 4 completed NCT02148562
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity No drug interventions Not Available Not Available unknown_status NCT02075294
Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B Not Available Not Available completed NCT01794234
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues No drug interventions Not Available Not Available terminated NCT01641926
A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450) treatment 3 terminated NCT01645969
A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265 No drug interventions Not Available Not Available completed NCT01529255
EFFORT Extension Study treatment 4 unknown_status NCT01519960
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B treatment 3 completed NCT01480622
Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects No drug interventions treatment 1 completed NCT01356901
Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients No drug interventions Not Available Not Available completed NCT01283074
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas) No drug interventions Not Available Not Available completed NCT01220596
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. treatment 3 unknown_status NCT01179594
A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B. treatment 4 withdrawn NCT01163240
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT01155427
Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB) No drug interventions Not Available Not Available completed NCT01128686
Lamivudine(LAM) Good Responder Study No drug interventions Not Available Not Available completed NCT01095835
A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV) treatment 3 completed NCT01013272
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load treatment Not Available completed NCT01023230
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B treatment 1 completed NCT01011738
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys No drug interventions Not Available Not Available completed NCT00860626
Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B No drug interventions treatment Not Available unknown_status NCT00810524
Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection treatment 4 unknown_status NCT00661076
ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B treatment 3 completed NCT00710216
Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B treatment 4 withdrawn NCT00625560
Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA treatment 4 completed NCT00536263
PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327) treatment 3 completed NCT00512941
Laboratory Profile of Hepatitis B and C in Users of a Reference Service No drug interventions Not Available Not Available completed NCT00423891
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection treatment 1 / 2 completed NCT00442572
SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB). treatment 2 completed NCT00435825
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB). treatment 4 completed NCT00436163
A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B treatment 4 completed NCT00410072
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B treatment 3 completed NCT00395018
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection prevention 3 completed NCT00154869
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C treatment 3 unknown_status NCT05133856
A Study of TAF in Combination With PEG-IFN and Hepalatide in Subjects With Chronic Hepatitis B treatment 2 not_yet_recruiting NCT04288310
A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection treatment 2 recruiting NCT02937779
Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission prevention 4 unknown_status NCT01745822
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand prevention 3 completed NCT01651403
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection treatment 3 active_not_recruiting NCT03559790
Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea Not Available Not Available unknown_status NCT05345990
Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins treatment 2 recruiting NCT06573190
Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B Not Available Not Available completed NCT00736190
A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection treatment 4 completed NCT04465890
A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients treatment 2 active_not_recruiting NCT01694264
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα prevention 3 terminated NCT04980664
Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China No drug interventions other Not Available unknown_status NCT04997564
The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China treatment 4 unknown_status NCT04182321
Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis B treatment Not Available completed NCT05771402
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B) No drug interventions treatment 4 not_yet_recruiting NCT02365402
Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment treatment 4 unknown_status NCT00605384
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection treatment 3 terminated NCT02387684
Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients No drug interventions Not Available Not Available unknown_status NCT05956379
Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention. No drug interventions treatment Not Available enrolling_by_invitation NCT01524679
Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen treatment 2 completed NCT01360879
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease No drug interventions Not Available Not Available unknown_status NCT01242787
Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B treatment 2 unknown_status NCT01813487
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E treatment Not Available completed NCT05310487
Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects No drug interventions treatment 1 completed NCT06092333
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B treatment 2 not_yet_recruiting NCT02581033
Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients No drug interventions treatment Not Available unknown_status NCT01192854
An Study of Efficacy and Safety of Clevudine treatment 3 completed NCT01533051
Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B No drug interventions Not Available Not Available unknown_status NCT02355951
Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection No drug interventions screening Not Available completed NCT01380951
Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB) treatment 4 unknown_status NCT03434353
Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB) treatment 2 terminated NCT06085053
A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects No drug interventions treatment 1 recruiting NCT00023153
Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection treatment 3 completed NCT00354653
A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone treatment 4 completed NCT02822547
Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults treatment 4 unknown_status NCT04112147
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B treatment 2 unknown_status NCT00226447
Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients treatment 2 completed NCT04781647
A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection treatment 2 terminated NCT00048945
Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B treatment 3 completed NCT04431245
Stopping Antiviral Treatment in Chronic Hepatitis B Not Available Not Available active_not_recruiting NCT00467545
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B treatment 4 completed NCT05828745
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B No drug interventions treatment 1 / 2 recruiting NCT05961098
A Study of RBD1016 in CHB Participants No drug interventions treatment 2 recruiting NCT00142298
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies treatment 3 completed NCT00781105
Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B treatment 4 completed NCT01594905
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection treatment 4 unknown_status NCT00116805
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B treatment 3 completed NCT04277897
A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers. No drug interventions treatment 1 unknown_status NCT05357183
The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia No drug interventions Not Available Not Available recruiting NCT02452528
Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus treatment 2 terminated NCT04646928
Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients No drug interventions Not Available Not Available unknown_status NCT06295328
From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients treatment 1 / 2 recruiting NCT01928511
Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy treatment 4 completed NCT04423393
Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection treatment 1 completed NCT00042393
An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options Not Available Not Available approved_for_marketing NCT06047093
Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients basic_science Not Available recruiting NCT05466071
Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load No drug interventions Not Available Not Available recruiting NCT05792878
Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy Not Available Not Available recruiting NCT00869778
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B No drug interventions treatment 2 completed NCT02069678
Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT01270178
Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy Not Available Not Available unknown_status NCT02792088
Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues treatment 3 completed NCT03672188
Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B treatment 1 / 2 completed NCT01926288
Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B treatment 4 completed NCT02249988
Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B treatment 2 / 3 completed NCT01872988
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma treatment 3 terminated NCT04507607
Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection health_services_research 0 unknown_status NCT02505009
Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy treatment 4 completed NCT01911156
Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues No drug interventions treatment 4 unknown_status NCT04672915
Prevalence of Occult Hepatitis B Virus Infection（OBI） in Subjects With Chronic Hepatitis B（CHB） Family History No drug interventions Not Available Not Available unknown_status NCT00715715
Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients treatment Not Available withdrawn NCT02774837
Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B treatment 4 unknown_status NCT01831037
The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study No drug interventions Not Available Not Available withdrawn NCT04536337
A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects treatment 1 recruiting NCT00225537
4-Methylumbelliferone as a Treatment for Chronic HBV/HCV treatment 2 unknown_status NCT03215732
Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal No drug interventions Not Available Not Available completed NCT02589652
Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy Not Available Not Available unknown_status NCT01401400
Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study No drug interventions Not Available Not Available completed NCT02965859
The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B treatment 2 unknown_status NCT00597259
Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B treatment 4 unknown_status NCT06263959
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B No drug interventions treatment 2 recruiting NCT04032275
Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV Infection No drug interventions Not Available Not Available completed NCT00857675
A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B No drug interventions treatment 3 completed NCT04891770
Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB) treatment 2 completed NCT00307242
Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B treatment 4 completed NCT00131742
Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B treatment 3 completed NCT05435599
Serum Regucalcin Level and Chronic Hepatitis B No drug interventions diagnostic Not Available completed NCT03173599
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers treatment 1 completed NCT04157699
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b treatment 2 unknown_status NCT01937806
Phase 3 and Extensional Study of Besifovir treatment 3 unknown_status NCT06357806
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients treatment Not Available recruiting NCT05871749
Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT02560649
An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients treatment 4 unknown_status NCT00645736
CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study No drug interventions Not Available Not Available completed NCT02049736
Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases treatment Not Available withdrawn NCT03038113
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B No drug interventions basic_science 1 completed NCT02979613
Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed treatment 3 completed NCT01965418
A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial No drug interventions treatment 4 unknown_status NCT02894918
A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAs treatment 4 unknown_status NCT05853718
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women treatment 4 recruiting NCT00973219
Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load treatment Not Available completed NCT00409019
Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy treatment 4 withdrawn NCT04939441
Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF) treatment 4 active_not_recruiting NCT05705141
The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B No drug interventions Not Available Not Available not_yet_recruiting NCT05637541
Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets No drug interventions treatment 2 recruiting NCT05423834
Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir Not Available Not Available active_not_recruiting NCT03356834
Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF treatment 4 recruiting NCT06311734
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection No drug interventions treatment 1 active_not_recruiting NCT03770624
A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA No drug interventions treatment 1 unknown_status NCT02474316
Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients treatment 4 unknown_status NCT05017116
A Single and Repeated Dose Escalation of RBD1016 in Subjects With Chronic Hepatitis B Virus (HBV) Infection treatment 1 completed NCT00778596
Prednisolone Priming Study in Patients With Chronic Hepatitis B treatment 4 unknown_status NCT04069858
Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B treatment 4 unknown_status NCT03752658
TAF Real World Study for Universal Effectiveness Not Available Not Available unknown_status NCT05808335
A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug) No drug interventions treatment 2 recruiting NCT01935635
A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB treatment 1 / 2 completed NCT04485663
A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects No drug interventions treatment 1 terminated NCT02387463
Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients No drug interventions Not Available Not Available completed NCT01065363
Health Promotion and Management for Hepatitis B Carriers No drug interventions prevention Not Available unknown_status NCT05661786
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase No drug interventions Not Available Not Available recruiting NCT01726439
Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China No drug interventions Not Available Not Available completed NCT01436539
Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients treatment 4 unknown_status NCT03429439
Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B No drug interventions treatment Not Available unknown_status NCT02615639
A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB treatment 1 / 2 unknown_status NCT04637139
A Study to Evaluate the Mass Balance Absorption and AME of VBR treatment 1 completed NCT03585322
APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B treatment 1 completed NCT01760122
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B treatment 3 completed NCT05001022
A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects No drug interventions treatment 1 terminated NCT00804622
Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB) treatment 2 completed NCT06289725
Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis B No drug interventions Not Available Not Available recruiting NCT01817725
Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg treatment 1 completed NCT02899130
Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B Virus No drug interventions treatment Not Available unknown_status NCT06364930
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus treatment 4 recruiting NCT03109730
Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B treatment 1 / 2 completed NCT05561530
A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects No drug interventions treatment 1 terminated NCT02862548
Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant treatment 2 completed NCT06566248
A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B No drug interventions treatment 2 recruiting NCT04157257
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy treatment 2 unknown_status NCT02349126
Study of ARC-520 in Patient With Chronic Hepatitis B Virus No drug interventions treatment 2 withdrawn NCT04864366
Efficacy and Safety of TAF for 48 Weeks in HBeAg Positive CHB Patients Not Available Not Available active_not_recruiting NCT01878565
The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion No drug interventions treatment 1 / 2 unknown_status NCT00057265
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B treatment 3 completed NCT01020565
A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection treatment 2 completed NCT00441974
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients treatment 4 completed NCT04195074
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b treatment Not Available recruiting NCT05808374
Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B No drug interventions basic_science 1 recruiting NCT05451420
Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy No drug interventions treatment Not Available completed NCT01925820
Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B treatment 4 unknown_status NCT00226382
Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment treatment 4 completed NCT02886182
Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB Infection No drug interventions Not Available Not Available unknown_status NCT06368882
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） No drug interventions treatment 4 recruiting NCT04496882
Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue treatment 4 unknown_status NCT05905731
Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B No drug interventions treatment 1 active_not_recruiting NCT04718831
Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients No drug interventions supportive_care Not Available completed NCT02332473
A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B treatment 2 completed NCT02202473
Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects treatment 4 completed NCT01204827
Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test No drug interventions diagnostic 2 / 3 withdrawn NCT00536627
Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis No drug interventions treatment 1 / 2 completed NCT05763576
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection No drug interventions treatment 1 recruiting NCT01148576
Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients treatment 4 unknown_status NCT04102176
Halting Nucleoside Analogues in Chronic Hepatitis B No drug interventions treatment Not Available unknown_status NCT04629976
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B treatment 1 completed NCT01198860
Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B Not Available Not Available approved_for_marketing NCT05317260
Steatohepatitis in Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT00798460
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients treatment 4 terminated NCT01264094
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period treatment 4 terminated NCT00907894
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B other 1 completed NCT04846491
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B treatment 3 completed NCT02793791
Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients No drug interventions prevention Not Available unknown_status NCT01037062
An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection treatment 2 completed NCT05753280
Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB treatment 4 completed NCT00338780
Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) No drug interventions treatment 4 completed NCT01906580
Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B treatment 4 unknown_status NCT03332329
Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients treatment 4 unknown_status NCT00412529
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B treatment 3 completed NCT01958229
Efficacy Study of Telbivudine in Chronic Hepatitis B Patients No drug interventions Not Available Not Available completed NCT00507689
Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant prevention 2 completed NCT00035789
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen treatment 3 completed NCT01360892
Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography No drug interventions Not Available Not Available unknown_status NCT02412592
Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy No drug interventions Not Available Not Available unknown_status NCT00040144
Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B treatment 2 terminated NCT02533544
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B Not Available Not Available completed NCT05238844
A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection treatment 2 terminated NCT05960240
Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects. No drug interventions treatment 1 recruiting NCT03642340
A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo No drug interventions Not Available Not Available unknown_status NCT05727267
A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate treatment 1 recruiting NCT01732367
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA treatment 4 completed NCT00531167
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B treatment 4 completed NCT01412567
Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers prevention Not Available completed NCT05130567
A Study of LP-128 Capsules in Healthy Subjects No drug interventions treatment 1 active_not_recruiting NCT00988767
Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B No drug interventions treatment 1 completed NCT04454567
A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors treatment 2 terminated NCT01022801
A Phase II Dose Response Study in Japan in Chronic Hepatitis B treatment 2 completed NCT00071201
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B treatment 3 completed NCT01326546
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients treatment 2 completed NCT03847246
Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers treatment Not Available completed NCT05286346
Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B treatment 4 completed NCT02973646
Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection treatment 4 unknown_status NCT01588912
Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir treatment 4 unknown_status NCT00635310
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin No drug interventions Not Available Not Available unknown_status NCT01026610
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B treatment 2 completed NCT06323681
Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study） No drug interventions treatment Not Available recruiting NCT05760781
To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B No drug interventions treatment 2 terminated NCT01464281
A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml No drug interventions treatment Not Available unknown_status NCT00263614
Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. No drug interventions Not Available Not Available completed NCT04896255
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B Not Available Not Available recruiting NCT06313255
A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance No drug interventions Not Available Not Available recruiting NCT03905655
Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B treatment 2 completed NCT03253250
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection treatment 4 unknown_status NCT04674423
The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury. treatment 4 recruiting NCT04301908
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis No drug interventions Not Available Not Available unknown_status NCT00036608
A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine treatment 3 completed NCT03209908
The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal Time Not Available Not Available unknown_status NCT01834508
3E Extension Study treatment 4 unknown_status NCT03575208
Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B treatment 2 withdrawn NCT03349008
Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B treatment 4 unknown_status NCT00275938
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B treatment 2 / 3 completed NCT02805738
Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet treatment 3 unknown_status NCT01532843
Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB treatment 4 completed NCT03780543
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients treatment 2 terminated NCT05760703
Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B No drug interventions treatment 2 terminated NCT02167503
Observational Study on Patients With Chronic Hepatitis B No drug interventions Not Available Not Available unknown_status NCT02362490
Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues treatment 4 unknown_status NCT04643990
LDT Combined With TDF to Improve EGFR Decreasing in Patients With Chronic Hepatitis B Treated With TDF No drug interventions Not Available Not Available unknown_status NCT03308890
The Effect of Entecavir Consolidation on Post-TDF Treatment Durability other 4 unknown_status NCT05147090
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B treatment 4 recruiting NCT00095121
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B treatment 3 completed NCT04759521
Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography No drug interventions Not Available Not Available completed NCT03038802
A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection treatment 1 / 2 not_yet_recruiting NCT03214302
The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus Infection treatment Not Available unknown_status NCT02348502
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment No drug interventions Not Available Not Available unknown_status NCT01373684
PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients treatment 4 completed NCT00393484
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection treatment 4 completed NCT01743079
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B prevention 4 completed NCT01804387
Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study treatment 4 unknown_status NCT01671787
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B treatment 1 completed NCT02017587
Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection No drug interventions Not Available Not Available unknown_status NCT01769833
HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance treatment 3 unknown_status NCT01595633
Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy treatment 4 unknown_status NCT03180333
The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers treatment 1 completed NCT00117533
Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta treatment 4 unknown_status NCT04464733
Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects No drug interventions other 1 unknown_status NCT00035633
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen treatment 3 completed NCT01264133
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B treatment 4 terminated NCT01264354
An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B treatment 4 completed NCT02738554
Off Treatment Durability in Chronic Hepatitis B With Good Immune Control No drug interventions other Not Available completed NCT06070051
Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy No drug interventions treatment 1 recruiting NCT04202653
Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) treatment 2 unknown_status NCT03491553
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B treatment 2 completed NCT04518553
Plasma Purification and Chronic Hepatitis B No drug interventions treatment Not Available unknown_status NCT06457477
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients treatment Not Available recruiting NCT02523547
Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude treatment 4 unknown_status NCT06184347
Population-wide Research for HBV-related Liver Diseases in Maoming City No drug interventions Not Available Not Available not_yet_recruiting NCT02166047
Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants treatment 2 completed NCT02883647
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b Not Available Not Available unknown_status NCT00115245
Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B treatment 3 completed NCT01266005
A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients treatment 4 terminated NCT06221605
Regulation of Intestinal Flora by Compound Probiotics in Patients With Chronic Hepatitis B No drug interventions treatment Not Available not_yet_recruiting NCT00146705
Long Term Follow-up of Pegylated-Interferon Alpha-2b No drug interventions Not Available Not Available completed NCT03734783
IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHB No drug interventions Not Available Not Available completed NCT04551261
GLS4/RTV and TAF Drug-drug Interaction other 1 completed NCT00324961
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B treatment 4 completed NCT04650828
TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months Not Available Not Available unknown_status NCT02594293
Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy prevention 4 completed NCT04676893
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects No drug interventions treatment 1 unknown_status NCT00558493
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients treatment 4 completed NCT03577171
A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV) treatment 2 completed NCT03366571
Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy Not Available Not Available active_not_recruiting NCT02125071
Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation No drug interventions Not Available Not Available completed NCT06154278
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B basic_science 2 recruiting NCT05189288
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects No drug interventions treatment 1 completed NCT02368288
Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment treatment 4 unknown_status NCT02300688
Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers Not Available 1 completed NCT03439488
A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B No drug interventions other 1 completed NCT01264107
An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine No drug interventions Not Available Not Available completed NCT05282407
A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B treatment 4 completed NCT03181607
Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV No drug interventions Not Available Not Available unknown_status NCT00507507
A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT) treatment 2 completed NCT04028856
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT02817685
Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial No drug interventions Not Available Not Available unknown_status NCT01829685
Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy treatment 4 unknown_status NCT03244085
A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients No drug interventions treatment 1 unknown_status NCT01342185
Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B No drug interventions treatment 3 unknown_status NCT05671315
A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients treatment Not Available recruiting NCT00936715
Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States treatment 2 completed NCT06130137
Gut Microbiome in People Living With HIV and HBV No drug interventions Not Available Not Available not_yet_recruiting NCT02401737
Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients treatment 1 completed NCT05298332
Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects treatment 1 terminated NCT00199732
Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a No drug interventions Not Available Not Available completed NCT04539652
Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients No drug interventions treatment 4 completed NCT01589952
Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) treatment 1 / 2 unknown_status NCT03733652
Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients treatment Not Available unknown_status NCT03714152
A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B No drug interventions treatment 1 completed NCT00132652
Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B treatment 3 completed NCT05721300
Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer treatment Not Available recruiting NCT02428400
Safety and Tolerability of TG1050: A Dose-finding Study No drug interventions treatment 1 completed NCT04519359
Biomarkers Guided Stopping NAs Treatment No drug interventions prevention Not Available unknown_status NCT05273775
A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers basic_science 1 completed NCT01887275
A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B No drug interventions treatment 4 completed NCT04779970
COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections No drug interventions treatment Not Available active_not_recruiting NCT02112799
Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients treatment 1 completed NCT06162299
A Phase I, The Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002 No drug interventions treatment 1 not_yet_recruiting NCT02336399
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment No drug interventions Not Available Not Available unknown_status NCT00606099
Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B treatment 4 withdrawn NCT02862106
Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B No drug interventions treatment 2 completed NCT05766449
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD No drug interventions Not Available Not Available recruiting NCT05483049
Prevalence of Significant Liver Fibrosis and Inflammation in Chronic HBV Infected Patients in Grey Zone No drug interventions Not Available Not Available unknown_status NCT01063036
Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment treatment 3 completed NCT02364336
Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment treatment 2 completed NCT05490836
Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients No drug interventions treatment Not Available not_yet_recruiting NCT03032536
Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers treatment 1 terminated NCT02532413
Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B treatment 4 unknown_status NCT02031913
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD No drug interventions Not Available Not Available completed NCT02901418
A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk Not Available Not Available unknown_status NCT00558818
Long-term Study With Clevudine treatment 4 completed NCT03792919
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) treatment 4 recruiting NCT00316719
Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients treatment 3 completed NCT03180619
Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) treatment 2 completed NCT02463019
Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B treatment 4 unknown_status NCT02565719
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection treatment 2 completed NCT03241641
Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. treatment 4 completed NCT05569941
A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects No drug interventions treatment 1 completed NCT06425341
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B No drug interventions treatment 2 recruiting NCT06280534
Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects No drug interventions treatment 1 recruiting NCT04398134
A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection treatment 2 terminated NCT01597934
Antiviral Efficacy of Switching to ETV Plus TDF treatment 4 unknown_status NCT02893124
The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg treatment 4 unknown_status NCT04501224
The Efficacy and Safety of TAF vs Other NAs in Patients With LVL treatment Not Available unknown_status NCT05769816
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) No drug interventions treatment 4 not_yet_recruiting NCT04083716
A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults No drug interventions treatment 1 completed NCT00291616
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B No drug interventions treatment 4 completed NCT01546116
Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) treatment 4 completed NCT00970216
Study of Telbivudine in Chronic Hepatitis B Not Available Not Available completed NCT00895596
Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B treatment 1 / 2 completed NCT05905458
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs) No drug interventions treatment 2 active_not_recruiting NCT05357235
The Study on Optimal Treatment and Clinical Outcome of Chronic Hepatitis B Patients With Inactive Hypoviremia No drug interventions Not Available Not Available recruiting NCT01471535
HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated treatment Not Available completed NCT01728935
Tenofovir in Asian Chronic Hepatitis B Patients treatment Not Available completed NCT05786963
Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis No drug interventions Not Available Not Available recruiting NCT04412863
Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection treatment 2 active_not_recruiting NCT02908763
HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients treatment 4 unknown_status NCT00298363
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. treatment 2 completed NCT04820686
A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection treatment 2 terminated NCT00221286
Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients treatment 3 terminated NCT06513286
TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate treatment 1 / 2 not_yet_recruiting NCT05717686
A Study Evaluating AHB-137 in Healthy Participants and Participants With Chronic Hepatitis B No drug interventions treatment 1 active_not_recruiting NCT05839639
A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors No drug interventions treatment 2 completed NCT00037622
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. No drug interventions treatment Not Available terminated NCT03357822
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B treatment 4 unknown_status NCT01522625
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation treatment 4 completed NCT00140725
Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) treatment 3 completed NCT02056548
Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy No drug interventions Not Available Not Available unknown_status NCT05523648
Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD treatment 0 completed NCT06535048
Impact of Fatty Liver on Hepatitis B Therapy Not Available Not Available active_not_recruiting NCT02566148
Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France No drug interventions Not Available Not Available completed NCT02589457
Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet treatment 1 completed NCT00001457
Lamivudine for Chronic Hepatitis B treatment 2 completed NCT05244057
A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients treatment 2 completed NCT02863757
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease No drug interventions Not Available Not Available recruiting NCT02287857
Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B treatment Not Available unknown_status NCT01037166
Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy treatment 2 completed NCT03576066
A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection treatment 2 completed NCT01531166
A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon Not Available Not Available completed NCT03615066
Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment treatment 2 completed NCT01027065
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients treatment 1 / 2 unknown_status NCT01270165
Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B treatment 3 unknown_status NCT04543565
Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study No drug interventions treatment 3 recruiting NCT00964665
Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects treatment 1 / 2 terminated NCT00388674
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection Not Available Not Available completed NCT03753074
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines treatment 4 active_not_recruiting NCT05457920
Study on Clinical Program Optimization of Inactive Hepatitis B Surface Antigen (HBsAg) Carriers (IHCs) No drug interventions treatment Not Available recruiting NCT02579382
Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated treatment 2 completed NCT04980482
Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection treatment 2 active_not_recruiting NCT06384131
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection No drug interventions treatment 1 not_yet_recruiting NCT02053727
Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background treatment Not Available withdrawn NCT02337127
Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents treatment 4 unknown_status NCT00117676
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B treatment 3 completed NCT05755776
The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment No drug interventions Not Available Not Available recruiting NCT03638076
The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules treatment 2 completed NCT00277576
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection No drug interventions treatment 1 completed NCT01487876
Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients No drug interventions treatment 2 unknown_status NCT02174276
Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment treatment 2 completed NCT00877760
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B treatment 4 completed NCT03108794
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B No drug interventions Not Available Not Available recruiting NCT04480294
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients No drug interventions other 1 unknown_status NCT02908191
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B treatment 1 completed NCT01337791
Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels treatment 4 completed NCT01267162
Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients No drug interventions Not Available Not Available completed NCT04142762
A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults treatment 1 completed NCT01143662
Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B treatment 2 completed NCT03740789
Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase Levels No drug interventions Not Available Not Available unknown_status NCT00307489
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil treatment 2 completed NCT01172392
A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B treatment 3 unknown_status NCT04271592
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults treatment 1 completed NCT03448744
Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients treatment 4 unknown_status NCT00883844
PEG-IFN in HBV Patients With Incomplete Response to NA No drug interventions treatment 4 completed NCT01997944
Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients treatment 1 / 2 completed NCT00397540
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) No drug interventions treatment Not Available completed NCT01711567
Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir treatment 4 completed NCT01277601
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B treatment 4 completed NCT02745704
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg No drug interventions treatment 4 unknown_status NCT05264272
Disease Loads and Status of Treatment No drug interventions Not Available Not Available recruiting NCT02569372
A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients treatment 1 completed NCT03662568
A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects treatment 1 completed NCT05793268
Finite Versus Continuous Nucleos(t)Ide Analogues for Chronic Hepatitis B treatment Not Available active_not_recruiting NCT00513968
Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine treatment 1 completed NCT01679769
Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT03777969
Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients No drug interventions Not Available Not Available active_not_recruiting NCT02838810
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg No drug interventions treatment 4 unknown_status NCT01260610
Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients treatment Not Available withdrawn NCT05414981
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection No drug interventions treatment 1 completed NCT03042481
Off-therapy Response After Stopping Entecavir or Tenofovir No drug interventions Not Available Not Available unknown_status NCT05343481
Efficacy of VTP-300 in Chronic Hepatitis B Infection treatment 2 recruiting NCT01243281
Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B treatment Not Available unknown_status NCT02258581
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection Not Available Not Available terminated NCT05841095
Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 No drug interventions treatment 1 / 2 recruiting NCT02476695
FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis No drug interventions Not Available Not Available unknown_status NCT01491295
Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients treatment 4 unknown_status NCT05770895
Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B No drug interventions treatment 1 active_not_recruiting NCT01776814
Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea No drug interventions Not Available Not Available unknown_status NCT05295914
Performance of Novel Simplified Score for Chronic Hepatitis B Treatment Eligibility in Thailand No drug interventions Not Available Not Available unknown_status NCT05797714
The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT. treatment Not Available active_not_recruiting NCT06150014
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B treatment 1 / 2 recruiting NCT02263755
Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT02932150
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection No drug interventions treatment 2 recruiting NCT04850950
Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B prevention 4 unknown_status NCT04180150
A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B treatment 2 unknown_status NCT04139850
The Establishment of Korean Hepatitis B Patients Cohort Not Available Not Available recruiting NCT01627223
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation treatment 4 terminated NCT02058108
Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection treatment 3 terminated NCT02881008
Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B treatment 1 / 2 completed NCT01379508
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept treatment 4 completed NCT01374308
NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients treatment 3 unknown_status NCT06431438
Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets No drug interventions treatment 1 completed NCT02991638
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers treatment 3 unknown_status NCT03801538
The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg No drug interventions treatment 4 unknown_status NCT01320943
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB treatment 4 completed NCT03210506
The Changes of Cytokines During Antiviral Therapy treatment Not Available unknown_status NCT04135235
Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B No drug interventions Not Available Not Available unknown_status NCT04030039
Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention No drug interventions Not Available Not Available unknown_status NCT04638439
The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection treatment 1 unknown_status NCT03329820
Quality of Life and Health Utility of Patients With CHB Infections No drug interventions Not Available Not Available completed NCT05355467
Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum treatment 4 completed NCT03587467
Study on Gut Microbiota in Chronic HBV Infected Patients No drug interventions Not Available Not Available unknown_status NCT03208998
The Changes of Natural Killer Cells Frequency and Function During Antiviral Therapy treatment 4 unknown_status NCT03209011
The Changes of CD4+T Cells Frequency and Function During Antiviral Therapy treatment 4 unknown_status NCT03210493
The Changes of Treg Cells Frequency and Function During Antiviral Therapy treatment Not Available unknown_status NCT03209037
The Changes of CD8+T Cells Frequency and Function During Antiviral Therapy treatment 4 unknown_status NCT03210467
The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral Therapy No drug interventions Not Available Not Available unknown_status